Risk for adverse outcomes increased with antipsychotic use in dementia
Apr 19, 2024
Risks increased for stroke, venous thromboembolism, myocardial infarction, heart failure, fracture, pneumonia and acute kidney injury.
Lower risk for MCI, dementia seen with cognitively stimulating occupations
Apr 17, 2024
Participants in a high versus low routine task intensity group had a higher risk for mild cognitive impairment and dementia.
Menopausal hormone therapy use beyond 65 years beneficial
Apr 16, 2024
Use of menopausal hormone therapy beyond age 65 years is associated with risk reductions in mortality as well as specific cancers and cardiovascular diseases, according to a study published online April...
Distance to neurologist, PCP may explain Alzheimer’s disease disparities
Apr 05, 2024
Non-Hispanic American Indian and/or Alaska Native and Hispanic decedents have to travel further to neurologist than non-Hispanic whites.
Endocrine, vascular processes contribute to cognitive decline in women
Apr 03, 2024
Earlier menopause and higher vascular risk were synergistically associated with lower cognitive scores at follow-up.
Higher education may protect functioning with Alzheimer’s disease
Apr 03, 2024
The findings were seen among African American individuals, with greater protective effect in APOE ɛ4 noncarriers.
Delirium increases risk for subsequent death, dementia in older adults
Apr 02, 2024
A dose-response association was seen with higher risk for each additional delirium episode.
Smartphone-based measures can help ID frontotemporal lobar degeneration
Apr 01, 2024
Individuals with frontotemporal lobar degeneration were accurately differentiated from controls with smartphone tests.
Inappropriate diagnosis of pneumonia common in hospitalized adults
Mar 27, 2024
Inappropriate diagnosis is common, especially in older patients and those with dementia or an altered mental status on presentation.
Burden of neurologic diagnoses lower after COVID-19 versus flu
Mar 20, 2024
Postinfection incident neurologic diagnoses were observed in 2.79 and 4.91% of the COVID-19 and influenza cohorts, respectively.